Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled
用户EO9nReo4Hj6s
1小时前
5
10
求助中
帖子自动结束时间: 2025-12-06 13:25:09
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2213-2600(25)00209-7
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213260025002097
其他信息:
出版社: Elsevier BV
作者: Shun Lu; Oleksandr Vynnychenko; Yaroslav Kulyaba; Vladimer Kuchava; Aishah Ibrahim; Fedor Moiseenko; Cagatay Arslan; Duong Thanh Nguyen; Marina Petrovic; Irfan Cicin; Khatuna Bibichadze; Timucin Cil; Jianhua Shi; Omer Fatih Olmez; Miranda Gogishvili; Mehmet Artac; Hoang Gia Nguyen; Mark Cornfeld; Chuan Tian; Mihaela C Munteanu; Claudia V M Sette; Igor Bondarenko
